Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Human SMAD1, MYC/DDK-tagged

Cat.No. : SMAD1-12H
Product Overview : Recombinant Human SMAD1, transcript variant 2, fused with C-terminal MYC/DDK, was expressed in HEK293 cells.
  • Specification
  • Gene Information
  • Related Products
Description : The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed.
Source : HEK293 cells
Species : Human
Tag : MYC/DDK
Molecular Mass : 52.1 kDa
Purity : > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration : >50 ug/mL as determined by microplate BCA method
Storage Buffer : 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.
Gene Name : SMAD1 SMAD family member 1 [ Homo sapiens (human) ]
Official Symbol : SMAD1
Synonyms : SMAD1; SMAD family member 1; BSP1; JV41; JV4-1; MADH1; MADR1; Sma- and Mad-related protein 1; Mad-related protein 1; TGF-beta signaling protein 1; mothers against DPP homolog 1; SMAD, mothers against DPP homolog 1; MAD, mothers against decapentaplegic homolog 1; transforming growth factor-beta signaling protein 1; MAD, mothers against decapentaplegic homolog 1 (Drosophila); SMAD, mothers against DPP homolog 1 (Drosophila); Mothers against decapentaplegic homolog 1; hSMAD1; BSP-1; CMT2D; GARS; HMN5; Mad-related protein 1; SMAD 1; Transforming growth factor-beta-signaling protein 1
Gene ID : 4086
mRNA Refseq : NM_001003688
Protein Refseq : NP_001003688
MIM : 601595
UniProt ID : Q15797
Chromosome Location : 4q31
Pathway : ALK1 signaling events; BMP receptor signaling; ErbB1 downstream signaling
Function : I-SMAD binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter sequence-specific DNA binding

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (5)

Ask a question
What technologies are commonly used to study the expression and activity of SMAD1 in clinical research? 04/12/2023

Techniques like Western blotting, immunohistochemistry, and qRT-PCR are commonly employed to study SMAD1 expression and activity in clinical research.

How might targeting SMAD1 have implications for anti-cancer therapies? 07/05/2022

Modulating SMAD1 activity could be explored as a potential strategy for developing anti-cancer therapies, particularly in cancers where the TGF-β pathway is dysregulated.

Are there any known genetic mutations in the SMAD1 gene associated with human diseases? 03/28/2021

Yes, mutations in the SMAD1 gene have been identified in certain individuals with congenital disorders and developmental abnormalities.

How does SMAD1 interact with other proteins in the TGF-β pathway? 01/08/2020

SMAD1 forms complexes with other SMAD proteins, transducing signals from TGF-β receptors to the nucleus, where they regulate gene expression.

How can SMAD1 be targeted for therapeutic interventions in bone-related disorders? 12/31/2019

Targeting SMAD1 or its downstream effectors in the TGF-β pathway may offer potential therapeutic strategies for bone-related disorders, such as osteoporosis.

Customer Reviews (3)

Write a review
Reviews
06/08/2022

    Whether I am investigating enzymatic activity, studying protein-protein interactions, or testing its role in signaling pathways, the SMAD1 protein consistently performs exceptionally well.

    08/08/2021

      This versatility allows me to explore different aspects of my research with confidence and accuracy.

      05/02/2018

        The SMAD1 protein's excellent functionality makes it highly suitable for various trial applications.

        Ask a Question for All SMAD1 Products

        Required fields are marked with *

        My Review for All SMAD1 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends